These medications work through multiple complementary mechanisms: they enhance glucose-dependent insulin secretion, suppress inappropriate glucagon release, slow gastric emptying, and reduce appetitecollectively improving glycaemic control whilst minimising the risk of hypoglycaemia
GHK exhibits a Cu 2+ affinity comparable to that of albumins copper transport sites, forming an in vivo complex, glycyl-L-histidyl-L-lysine-Cu 2+ (GHK-Cu), which enhances its bioavailability (Pickart, 2008)
What does GHK-Cu do in the body
FOXO4 plays a key role in regulating cell cycle control, stress resistance, and apoptosis, while p53 is a central regulator of DNA damage response and cellular aging
Liposomal delivery enhances absorption and bioavailability